Certified by Founder Lodge
OcuTerra Therapeutics
United States - Boston, MA
START UP
1 Disclosed Funding Rounds $35,000,000
0 Participating Investments
-
Founded date
2011
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Non-Invasive, Transformational Approach to Treating Retinal Disease.
OcuTerra is developing a novel eye drop, OTT166, designed to treat diabetic eye disease. This first-in-class, highly di
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| November, 09 ,2021 | Series B | $35,000,000 |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Transaera, Inc. | $10,500,000 | (Nov 5, 2024)
Algebrik AI | $4,000,000 | (Nov 5, 2024)
Insider. | $500,000,000 | (Nov 5, 2024)
Cintoo | $40,246,701 | (Nov 5, 2024)
Advex AI | $3,500,000 | (Nov 5, 2024)
